Literature DB >> 31776437

Phenotype categorization of neurofibromatosis type I and correlation to NF1 mutation types.

Eungu Kang1, Yoon-Myung Kim2, Go Hun Seo3, Arum Oh3, Hee Mang Yoon4, Young-Shin Ra5, Eun Key Kim6, Heyry Kim3, Sun-Hee Heo7, Gu-Hwan Kim8, Mark J Osborn9, Jakub Tolar9, Han-Wook Yoo3,8, Beom Hee Lee10,11.   

Abstract

Neurofibromatosis type 1 (NF1) is caused by heterozygous mutation in the NF1 gene. NF1 is one of the most common human genetic diseases. However, the overall genotype-phenotype correlation has not been known, due to a wide spectrum of genotypic and phenotypic heterogeneity. Here we describe the detailed clinical and genetic features of 427 Korean NF1 patients from 389 unrelated families. Long range PCR and sequencing of genomic DNA with multiplex ligation-dependent probe amplification analysis identified 250 different NF1 mutations in 363 families (93%), including 94 novel mutations. With an emphasis on phenotypes requiring medical attention (classified and termed: NF1+), we investigated the correlation of NF1+ and mutation types. NF1+ was more prevalent in patients with truncating/splicing mutations and large deletions than in those with missense mutations (59.6%, 64.3% vs. 36.6%, p = 0.001). This difference was especially significant in the patients younger than age 19 years. The number of items in NF1+ was a higher in the former groups (0.95 ± 0.06, 1.18 ± 0.20 vs. 0.56 ± 0.10, p = 0.002). These results suggest that mutation types are associated not only with higher prevalence of severe phenotypes in NF1 but also with their earlier onset.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31776437     DOI: 10.1038/s10038-019-0695-0

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  35 in total

1.  A clinical and genetic overview of 18 years neurofibromatosis type 1 molecular diagnostics in the Netherlands.

Authors:  R van Minkelen; Y van Bever; J N R Kromosoeto; C J Withagen-Hermans; A Nieuwlaat; D J J Halley; A M W van den Ouweland
Journal:  Clin Genet       Date:  2013-06-25       Impact factor: 4.438

2.  The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins.

Authors:  R Ballester; D Marchuk; M Boguski; A Saulino; R Letcher; M Wigler; F Collins
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

3.  The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21.

Authors:  G A Martin; D Viskochil; G Bollag; P C McCabe; W J Crosier; H Haubruck; L Conroy; R Clark; P O'Connell; R M Cawthon
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

Review 4.  Guidelines for the diagnosis and management of individuals with neurofibromatosis 1.

Authors:  Rosalie E Ferner; Susan M Huson; Nick Thomas; Celia Moss; Harry Willshaw; D Gareth Evans; Meena Upadhyaya; Richard Towers; Michael Gleeson; Christine Steiger; Amanda Kirby
Journal:  J Med Genet       Date:  2006-11-14       Impact factor: 6.318

Review 5.  Epidemiology of neurofibromatosis type 1.

Authors:  J M Friedman
Journal:  Am J Med Genet       Date:  1999-03-26

6.  Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption.

Authors:  K Wimmer; X Roca; H Beiglböck; T Callens; J Etzler; A R Rao; A R Krainer; C Fonatsch; L Messiaen
Journal:  Hum Mutat       Date:  2007-06       Impact factor: 4.878

7.  Use of "unidentified bright objects" on MRI for diagnosis of neurofibromatosis 1 in children.

Authors:  K DeBella; K Poskitt; J Szudek; J M Friedman
Journal:  Neurology       Date:  2000-04-25       Impact factor: 9.910

8.  Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain.

Authors:  R Fahsold; S Hoffmeyer; C Mischung; C Gille; C Ehlers; N Kücükceylan; M Abdel-Nour; A Gewies; H Peters; D Kaufmann; A Buske; S Tinschert; P Nürnberg
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

9.  Nature and mRNA effect of 282 different NF1 point mutations: focus on splicing alterations.

Authors:  Eva Pros; Carolina Gómez; Thamar Martín; Pere Fábregas; Eduard Serra; Conxi Lázaro
Journal:  Hum Mutat       Date:  2008-09       Impact factor: 4.878

10.  NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience.

Authors:  Audrey Sabbagh; Eric Pasmant; Apolline Imbard; Armelle Luscan; Magali Soares; Hélène Blanché; Ingrid Laurendeau; Salah Ferkal; Michel Vidaud; Stéphane Pinson; Christine Bellanné-Chantelot; Dominique Vidaud; Béatrice Parfait; Pierre Wolkenstein
Journal:  Hum Mutat       Date:  2013-08-26       Impact factor: 4.878

View more
  9 in total

1.  The cryo-EM structure of the human neurofibromin dimer reveals the molecular basis for neurofibromatosis type 1.

Authors:  Christopher J Lupton; Charles Bayly-Jones; Laura D'Andrea; Cheng Huang; Ralf B Schittenhelm; Hari Venugopal; James C Whisstock; Michelle L Halls; Andrew M Ellisdon
Journal:  Nat Struct Mol Biol       Date:  2021-12-09       Impact factor: 15.369

2.  Application of Combined Long Amplicon Sequencing (CoLAS) for Genetic Analysis of Neurofibromatosis Type 1: A Pilot Study.

Authors:  Sumihito Togi; Hiroki Ura; Yo Niida
Journal:  Curr Issues Mol Biol       Date:  2021-07-23       Impact factor: 2.976

3.  Deletion of the whole NF1 gene in a three-generation family with neurofibromatosis type 1.

Authors:  Qin Du; Hongxi Chen; Hongyu Zhou
Journal:  Neurol Sci       Date:  2021-06-05       Impact factor: 3.307

4.  Spontaneous pneumothorax as a clinical manifestation of neurofibromatosis type 1.

Authors:  Tine Lorentzen; Hanne Madsen; Marie Josée Zareh Lausten-Thomsen; Anette Bygum
Journal:  BMJ Case Rep       Date:  2021-03-18

5.  Neurofibromatosis type I: points to be considered by general pediatricians.

Authors:  Eungu Kang; Hee Mang Yoon; Beom Hee Lee
Journal:  Clin Exp Pediatr       Date:  2020-07-15

6.  Identification of NF1 Frameshift Variants in Two Chinese Families With Neurofibromatosis Type 1 and Early-Onset Hypertension.

Authors:  Yi-Ting Lu; Di Zhang; Xin-Chang Liu; Qiong-Yu Zhang; Xue-Qi Dong; Peng Fan; Yan Xiao; Xian-Liang Zhou
Journal:  Front Pediatr       Date:  2021-12-20       Impact factor: 3.418

7.  Whole-body MRI evaluation in neurofibromatosis type 1 patients younger than 3 years old and the genetic contribution to disease progression.

Authors:  Eungu Kang; Yoon-Myung Kim; Yunha Choi; Yena Lee; JunYoung Kim; In Hee Choi; Han-Wook Yoo; Hee Mang Yoon; Beom Hee Lee
Journal:  Orphanet J Rare Dis       Date:  2022-01-29       Impact factor: 4.123

8.  Age-dependent oral manifestations of neurofibromatosis type 1: a case-control study.

Authors:  Eshwar Thota; John Jims Veeravalli; Sai Krishna Manchala; Bhargavi Priya Lakkepuram; Jayasurya Kodapaneni; Yi-Wen Chen; Li-Tzu Wang; Kevin Sheng-Kai Ma
Journal:  Orphanet J Rare Dis       Date:  2022-03-02       Impact factor: 4.123

9.  A case of solitary neurofibroma in the maxillary gingiva.

Authors:  Yuko Komatsu; Yasunori Takeda; Tadashi Kawai; Shunichi Sasou; Kazuaki Takahashi; Hiroyuki Yamada; Shu Ishibashi
Journal:  J Surg Case Rep       Date:  2022-07-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.